Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V47352 | Topoisomerase II inhibitor 6 | 2987586-62-7 | Topoisomerase II inhibitor 6 (Compound 5) is a tryptophan analogue that is a potent and specific inhibitor of topoisomerase II. |
![]() |
V45849 | Topoisomerase II inhibitor 7 | 2697171-03-0 | Topoisomerase II inhibitor 7 (compound 3a) is a potent inhibitor of topoisomerase II α subtype with IC50 of 3.19 μM. |
![]() |
V46115 | Topoisomerase II inhibitor 8 | 2493298-68-1 | Topoisomerase II inhibitor 8 (compound 22) is a potent topoisomerase II inhibitor (antagonist) with IC50 of 0.52 μM. |
![]() |
V45620 | Topoisomerase II inhibitor-10 | 2488208-96-2 | Topoisomerase II inhibitor 10 (compound 32a) is a potent topoisomerase II inhibitor (antagonist) with IC50 of 7.45 μM. |
![]() |
V47378 | Topoisomerase IIα-IN-1 | 2407521-87-1 | Topoisomerase IIα-IN-1 (compound 2) is a potent inhibitor of DNA-binding ligands and topoisomerase TopoIIα. |
![]() |
V47353 | Topoisomerase IIα-IN-2 | 2407521-90-6 | Topoisomerase IIα-IN-2 (compound 5) is a potent inhibitor of DNA-binding ligands and topoisomerase TopoIIα. |
![]() |
V48094 | Toremifene-d6 | Toremifene-d6 is thedeuterium labeled form of Toremifene (Z-Toremifene), which is a 2nd-generation selective estrogen-receptor modulator (SERM) for osteoporosis. | |
![]() |
V49173 | TP-0427736 HCl | 2459963-17-6 | TP0427736 HCl is a potent inhibitor of ALK5 kinase activity with IC50 of 2.72 nM, which is 300-fold greater than the inhibition of ALK3 (IC50 for ALK3 inhibition is 836 nM). |
![]() |
V43557 | TP-0480066 | 2245693-15-4 | TP0480066 is a selective topoisomerase II inhibitor (antagonist) with IC50s of 1.10 and 62.89 nM for DNA gyrase and topo IV, respectively. |
![]() |
V43947 | TP-5801 | 2574474-81-8 | TP-5801 is an orally bioactive non-receptor tyrosine kinase (TNK1) inhibitor (IC50=1.40 nM) and displays anti-tumor activity. |
![]() |
V46764 | TPB-15 | 2170347-69-8 | TPB15 is an orally bioavailable inhibitor of Hh (Hedgehog) signaling. |
![]() |
V46150 | TPBM | 6466-43-9 | TPBM is a potent estrogen receptor alpha (ERα) inhibitor (antagonist) with IC50 of 9 μM for 17β-estradiol (E2)-ERα. |
![]() |
V41748 | TPX-0046 | TPX-0046, RET/SRC inhibitor | |
![]() |
V48673 | Trametinib-13C,d3 | 2712126-59-3 | Trametinib-13C,d3 is a 13C- and deuterated-labeled trametinib. |
![]() |
V48286 | trans-4’-Hydroxy CCNU Lomustine-d4 | trans-4'-Hydroxy CCNU Lomustine-d4 is the deuterium labelled form of trans-4'-Hydroxy CCNU Lomustine. | |
![]() |
V48657 | trans-Dihydro Tetrabenazine-d7 | 1217744-19-8 | trans-Dihydro Tetrabenazine-d7 is (2S,3S,11bS)-3-Isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin -2-ol deuterated compounds. |
![]() |
V48087 | trans-Hydroxy Glimepiride-d4 | 2749985-37-1 | trans-Hydroxy Glimepiride-d4 is the deuterium labelled form of trans-Hydroxy Glimepiride. |
![]() |
V43854 | trans-N-Methyl-4-methoxyproline | 131559-49-4 | trans-N-Methyl-4-methoxyproline is a proline analogue extracted from the stems of Petiveria alliacea. |
![]() |
V48633 | trans-Resveratrol 4’-O-β-D-glucuronide-d4 | 1420291-58-2 | trans-Resveratrol 4'-O-β-D-glucuronide-d4 is the deuterium labelled form of Resveratrol-4'-OD-Glucuronide. |
![]() |
V48509 | trans-Zeatin-d5 | 72963-19-0 | trans-Zeatin-d5 is the deuterium labelled form of trans-Zeatin. |